[144] BITMINE IMMERSION TECHNOLOGIES, INC. SEC Filing

Rhea-AI Filing Summary

BitMine Immersion Technologies, Inc. (BMNR) insider Jonathan Robert Bates filed a Form 144 indicating proposed and recent sales of common stock. The filing lists a proposed sale of 50,000 shares through UBS Securities LLC (NYSE) with an aggregate market value of $2,755,000 and an approximate sale date of 09/22/2025. The securities were originally acquired on 12/20/2022 as executive compensation (375,000 shares acquired). The filing also discloses a sale completed on 09/11/2025 of 250,000 shares generating $10,136,778 in gross proceeds. The filer certifies no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider sales disclosed; routine compliance filing with material share dispositions reported.

The Form 144 documents both a recent large sale (250,000 shares for $10,136,778) and a proposed sale (50,000 shares valued at $2,755,000) executed through UBS Securities LLC. The shares were acquired as executive compensation on 12/20/2022. From a market perspective, insider dispositions of this size are material to monitor for potential signaling but the filing itself is a routine Rule 144 disclosure showing adherence to resale requirements. No earnings or corporate-operational details are provided to link these sales to company performance.

Corporate Governance Expert

TL;DR: Filing shows disclosure and attestation but raises governance questions about timing and insider liquidity.

The signer attests there is no undisclosed material adverse information and references Rule 10b5-1 trading-plan language without specifying a plan date. The disclosure of acquisition as executive compensation and subsequent large dispositions is transparent, but investors may seek clarity on whether sales were preplanned under a 10b5-1 program. The Form 144 meets statutory notice requirements but provides limited context on intent or linkage to corporate events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Securities LLC 11 Madison Avenue New York NY 10010	50000	2755000.00	279524602	09/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/20/2022	Executive Compensation	Company			375000	12/20/2022	Executive Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bates Jonathan Robert 10845 GRIFFITH PEAK DR. #2 LAS VEGAS NV 89135	Common Stock	09/11/2025	250000	10136778.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 filed for BMNR disclose?

The filing discloses a proposed sale of 50,000 common shares via UBS Securities with an aggregate market value of $2,755,000 and a completed sale on 09/11/2025 of 250,000 shares for $10,136,778.

Who is the seller named in the BMNR Form 144?

The filing identifies Jonathan Robert Bates as the person for whose account the securities are to be sold.

How were the shares acquired according to the filing?

The securities were acquired on 12/20/2022 as executive compensation, with an acquisition amount listed as 375,000 shares.

Through which broker will the proposed BMNR sale be executed?

The proposed sale lists UBS Securities LLC, 11 Madison Avenue, New York NY 10010 as the broker and NYSE as the exchange.

Does the filing state there is any undisclosed material information?

By signing the Form 144, the filer represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.